¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"minimal brain damage"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
¿µ¹® blood-brain barrier(BBB) ÇÑ±Û Ç÷³úÀ庮
¼³¸í   
  ³ú¿Í Ã´¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ´Ù. À̰ÍÀº ³ú¿Í Ã´¼ö¿¡ Á¸ÀçÇϴ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ºñ±³Àû ´Ù¸¥ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºº¸´Ù ¶³¾îÁö±â ¶§¹®ÀÌ´Ù.
¿µ¹® blood-brain barrier ÇÑ±Û Ç÷¾×³úÀ庮
¼³¸í   
  Ç÷¾×À¸·ÎºÎÅÍ ³ú·Î´Â ÁöÁú¿ëÇØ¼ºÀÌ ³ôÀº ¾à¹°¹Û¿¡ ÀÌÇàµÇÁö ¾Ê´Â´Ù. ¼ö¿ë¼ºÀÇ ¾à¹°À» ³ú·Î ÀÌÇàµÇÁö ¾Ê°Ô Çϰí Àִ °ÍÀÌ Ç÷¾×³úÀ庮À̸砳úÀÇ ¸ð¼¼Ç÷°ü ³»ÇǼ¼Æ÷, ¸ð¼¼Ç÷°ü ÁÖÀ§ÀÇ ¼¼Æ÷°¡ À庮ÀÌ µÇ°í ÀÖ´Ù. ¹°Áú±³È¯Àº ¼öµ¿È®»ê¿¡ ÀÇÇØ ÀÌ·ç¾îÁöÁö¸¸, ³úÀÇ »ý¸®Àû È°µ¿¿¡ ÇÊ¿äÇÑ ¹°ÁúÀº ÀÌ¿ÂÇüÀ̶󵵠´ãü¸¦ ÅëÇØ ÀÌÇàµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • minimal infecting dose
    ÃÖ¼Ò°¨¿°¿ë·®
  • minimal inhibitory concentration
    ÃÖÀú¾ïÁ¦³óµµ
  • minimal lethal dose
    1. ÃÖ¼ÒÄ¡»ç·® 2. ÃÖ¼ÒÄ¡»ç¼±·®
  • minimal stimulus
    ÃÖ¼ÒÀÚ±Ø
  • minimal tension line
    ÃÖ¼ÒÀå·Â¼±
  • minimal visible angle
    Ãּҽð¢
  • minimal volition period
    ÃÖ¼Ò¼öÃà±â
  • acute brain syndrome
    ±Þ¼º³úÁõÈıº
  • blood-brain barrier
    Ç÷¾×³úÀ庮
  • brain
    ³ú
  • brain abscess
    ³ú°í¸§Áý, ³ú³ó¾ç
  • brain CT
    ³úÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(¼ú)
  • brain death
    ³ú»ç
  • brain death syndrome
    ³ú»çÁõÈıº
  • brain infarct
    ³ú°æ»ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • brain infarct
    ³ú°æ»ö
  • brain map
    ³úÁÂÇ¥µµ
  • brain stem
    ³úÁÙ±â
  • brain vesicle
    ³ú¼ÒÆ÷
  • brain death syndrome
    ³ú»çÁõÈıº
  • brain function mapping
    ³ú±â´ÉÁöµµÈ­
  • brain natriuretic peptide
    ³ú³ªÆ®·ýÀÌ´¢ÆéƼµå
  • brain stem evoked potential
    ³úÁÙ±âÀ¯¹ßÀüÀ§
  • olfactory brain
    Èİ¢³ú
  • elective brain irradiation
    ¿¹¹æ³úÁ¶»ç
  • hypoxic brain injury
    Àú»ê¼Ò³ú¼Õ»ó
  • organic brain syndrome
    ±âÁú³úÁõÈıº
  • primary brain vesicles
    ÀÏÂ÷³úÆ÷
  • minimal visible angle
    Ãּҽð¢
  • minimal alveolar concentration
    ÃÖ¼ÒÆóÆ÷³»³óµµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • prolapse of brain
    ³úÅ»(ÃâÁõ)(Òà÷­(õóñø))
  • prosencephalon =fore brain
    Àü³ú.
  • prosencephalon =fore brain
    Àü³ú.
  • radiation brain necrosis
    ¹æ»ç¼±³ú±«»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • potentially lethal damage repair
    ÀáÀçÄ¡»ç¼Õ»óȸº¹
  • radiation damage
    ¹æ»ç¼±¼Õ»ó(Û¯ÞÒàÊáßß¿).
  • radiation damage
    ¹æ»ç¼±¼Õ»ó(Û¯ÞÒàÊáßß¿)
  • radiation damage
    ¹æ»ç¼±¼Õ»ó
  • renal damage
    ½ÅÀå¾Ö(ãìî¡äô)
  • repair of radiation damage
    ¹æ»ç¼± ¼Õ»ó º¹±¸
  • smoke damage
    ¿¬ÇØ(ËçÌ´).
  • sublethal damage
    ÁØÄ¡»ç¼Õ»ó
  • sublethal damage repair
    ÁØÄ¡»ç¼Õ»óȸº¹
  • tissue damage
    Á¶Á÷¼Õ»ó(ðÚòÄáßß¿)
  • water pollution damage
    ¼öÁú¿À¿°ÇÇÇØ (ÊṴ̴̀).
  • minimal air
    ÃÖ¼Ò°ø±â.
  • minimal angle resolution
    ÃÖ¼Ò°¢ºÐÇØ´É.
  • minimal auditory threshold
    ÃÖ¼Ò°¡Ã»¿ªÄ¡(õÌ á³Ê¦ôéÚÊö·).
  • minimal auditory threshold
    ÃÖ¼Ò°¡Ã»¿ªÄ¡
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
S-BD seizure-brain damage
MCD magnetic circular dichroism; mast-cell degranulation; mean cell diameter; mean of consecutive differ...
MIC maternal and infant care; medical intensive care; Medical Interfraternity Conference; microscopy; mi...
MPD main pancreatic duct; maximum permissible dose; mean population doubling; membrane potential differe...
MBD Minimal Brain Dysfuction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PLD Potentially lethal damage
PLDR Potentially lethal damage repair
TOD Target organ damage
DIN damage inducible
LHD left hemisphere damage
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • toxic damage
    µ¶¼º ¼Õ»ó
  • toxic mucosal damage
    µ¶¼º Á¡¸· ¼Õ»ó
  • vascular damage
    Ç÷°ü ¼Õ»ó
  • water pollution damage
    ¼öÁú ¿À¿° ÇÇÇØ
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö
  • atypical or mixed organic brain syndrome
    ºñÁ¤Çü ³»Áö È¥ÇÕÇü ±âÁú¼º ³ú ÁõÈıº
  • blood-brain barrier
    Ç÷³ú À庮
    ³ú¿Í ô¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ Á¸ÀçÇϰí À̰ÍÀ» Ç÷³ú À庮À̶ó ÇÑ´Ù. À̰ÍÀº ³ú¿Í ô¼ö¿¡ Á¸ÀçÇÏ´Â ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ´Ù¸¥ ¸ð¼¼Ç÷°ü¿¡ ºñÇØ ¶³¾îÁö±â ¶§¹®ÀÌ´Ù.
  • brain abscess
    ³ú ³ó¾ç
    ³ú ³ó¾çÀº ³ú ½ÇÁú³»¿¡ ¿©·¯ Á¾·ùÀÇ ¼¼±Õ, Áø±Õ, ¿øÃæ·ùµéÀÇ °¨¿°¿¡ ÀÇÇÏ¿© ¹ß»ýµÇ´Â ±¹ÇÑµÈ È­³ó¼º ÁúȯÀÌ´Ù. 1. ¿øÀÎ : ¿©·¯ Á¾·ùÀÇ ¼¼±Õ, Áø±Õ, È¿¸ð±Õ, ±â»ýÃæ µîÀÌ ³ú ³ó¾çÀ» ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¸ç, °ú°Å¿¡´Â ¿¬¼â»ó ±¸±Õ, Æ÷µµ»ó ±¸±Õ, Àå³»±Õ, Æó·Å ±¸±Õ µîÀÌ °¡Àå ÈçÇÑ ¿øÀαÕÀ̾úÀ¸³ª ±Ù·¡¿¡ ¿Í¼­ Ç×»ýÁ¦ÀÇ ±¤¹üÀ§ÇÑ »ç¿ë, ¸é¿ª°áÇÌÁõ ȯÀÚÀÇ Áõ°¡ µîÀ¸·Î ¼Ò °£±Õ, Çø±â¼º ¿¬¼â»ó ±¸±ÕÀÌ °¡Àå ÈçÇÑ ¿øÀαÕÀ¸·Î µÇ¾úÀ¸¸ç, Nocardia±Õ, Áø±Õ, ±â»ýÃæÀÇ ºóµµµµ ³ô¾ÆÁö°í ÀÖ´Ù. °¨¿° °æ·Î¸¦ º¸¸é ÁßÀÌ¿°À̳ª ºÎºñµ¿¿°¿¡¼­ Á÷Á¢ ¶Ç´Â ³ú ÇÇÁú, ³ú°æ¸·ÀÇ Á¤¸ÆÀ» ÅëÇÏ¿© °¨¿°µÇ°Å³ª µÎºÎÀÇ °üÅë»óÀ̳ª µÎºÎ ¼ö¼úÈÄÀÇ ÇÕº´ÁõÀ¸·Î Ç÷·ù¸¦ ÅëÇÑ ÆÐÇ÷¼º »öÀüÀ» ÅëÇÏ¿© ¶Ç´Â ¾Æ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°À̳ª ¼±Ãµ¼º ½ÉÀ庴 ±×¸®°í ¸é¿ª±â´ÉÀÌ ÀúÇÏµÈ °æ¿ì¿¡ ÁÖ·Î ¹ß»ýÇϸç, »ó´ç¼ö¿¡¼­´Â °¨¿° °æ·Î¸¦ ¸ð¸£´Â °æ¿ìµµ ÀÖ´Ù. 2. Áõ»ó : ´ëºÎºÐÀÇ ³ú ³ó¾çÀº 20¼¼ ÀÌÀü¿¡ ¹ß»ýµÇ´Âµ¥ ±× ÀÌÀ¯´Â ÀÌ ¿¬·É ±º¿¡¼­ ÁßÀÌ¿°À̳ª Ãà³óÁõÀÇ ºóµµ°¡ ³ôÀ¸¸ç, ¼±Ãµ¼º ½ÉÀ庴¿¡ ±âÀÎµÈ ³ú ³ó¾çÀÌ ÁÖ·Î ¼Ò¾Æ±â¿¡ ¹ß»ýµÇ±â ¶§¹®ÀÌ´Ù. 3´ë 2¿¡¼­ 2´ë 1ÀÇ ºñÀ²·Î ³²ÀÚ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ÁßÀÌ¿°¿¡¼­ ¹ß»ýµÈ °æ¿ì¿¡´Â ÁÖ·Î ÃøµÎ¿±¿¡ ¹ß»ýµÇ¸ç °¡²û ÃøµÎ¿±À̳ª ÅÍŰ¾È¿¡µµ »ý±ä´Ù. Ç÷¾×À» ÅëÇÏ¿© ÀüÀÌµÈ °æ¿ì°¡ ÃÖ±Ù Áõ°¡µÇ°í Àִµ¥ ´ëºÎºÐ ´Ù¹ß¼ºÀ̰ųª ±íÀº °÷¿¡ À§Ä¡Çϰí óÀ½ Áø´Ü ½Ã °æ°è°¡ È®½ÇÄ¡ ¾ÊÀº Ư¡ÀÌ ÀÖ¾î ¿¹Èİ¡ ÁÁÁö ¾ÊÀº ÆíÀÌ´Ù. ÁÖ Áõ»óÀ̳ª ½Å°æÇÐÀû ÀÌ»ó Á¤µµ´Â ³ó¾çÀÇ ºÎÀ§, Å©±â, º´¼ÒÀÇ ¼ö, ¿øÀαÕÀÇ µ¶¼º, ÁÖº¯ ³ú ºÎÁ¾ÀÇ Á¤µµ, °¨¿°¿¡ ´ëÇÑ ¼÷ÁÖÀÇ ¹ÝÀÀ µî¿¡ µû¶ó ´Ù¸£¸ç ÀϹÝÀûÀ¸·Î ³ú Á¶Á÷ÀÇ ÆÄ±«¿Í Á¾±« È¿°ú¿¡ µû¶ó µÎ°³°­ ³»¾ÐÀÇ »ó½Â°ú ±¹¼Ò¼º ½Å°æÇÐÀû Àå¾Ö¸¦ ÀÏÀ¸Å²´Ù. Áõ»ó ¹ßÇö°ú Áø´Ü±îÁöÀÇ ±â°£Àº 75%¿¡¼­ 2ÁÖ À̳»ÀÌ¸ç °¡Àå ÈçÇÑ Áõ»óÀº Á¡Â÷ ½ÉÇØÁö´Â µÎÅëÀ¸·Î 70-95%ÀÇ È¯ÀÚ¿¡¼­ ³ªÅ¸³ª¸ç ÁÖ·Î ¿À½É°ú ±¸Å並 µ¿¹ÝÇÑ´Ù. ¹ßÀÛÀÌ 30-50%ÀÇ È¯ÀÚ¿¡¼­ ³ªÅ¸³ª°í ¹Ý¼öÀÇ È¯ÀÚ¿¡¼­ ¹Ì¿­ÀÌ ³ªÅ¸³ªÁö¸¸ 39µµ ÀÌ»óÀÇ °í¿­Àº µå¹°´Ù. ¼Ò³ú ³ó¾çÀÇ °æ¿ì¿¡´Â Çö±âÁõÀ̳ª ÇöÈÆÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ÀÔ¿ø½Ã ¾à ¹Ý¼öÀÇ È¯ÀÚ¿¡¼­´Â ¹ß¿­ µîÀÇ Àü½Å Áõ»óÀÌ ³ªÅ¸³ª¸ç µÎ°³°­ ³»¾ÐÀÇ »ó½ÂÀ¸·Î 23-50%¿¡¼­ À¯µÎ ºÎÁ¾À» º¼ ¼ö ÀÖ´Ù. ÀÔ¿ø ½Ã¿¡ ¹Ý¼ö À̻󿡼­ ÀÇ½Ä Àå¾Ö°¡ ÀÖÀ¸¸ç °æÇÑ ÀǽÄÀÇ Àå¾Ö·ÎºÎÅÍ È¥¼ö »óűîÁö ¿©·¯ Á¤µµ·Î ³ªÅ¸³­´Ù. óÀ½ ÀǽÄÀÇ Á¤µµ°¡ ȯÀÚÀÇ ¿¹ÈÄ¿¡¼­ °¡Àå Áß¿äÇÏ´Ù. ³ú ÇÇÁúÀ̳ª ³ú ÇÇÁú ÇϺÎÀÇ Æ¯Á¤ÇÑ ºÎÀ§ÀÇ ¼Õ»óÀ¸·Î ±¹¼Ò¼º ½Å°æÇÐÀû Àå¾Ö¸¦ ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¸ç ¹Ý½Å ¸¶ºñ, ¾ð¾îÀå¾Ö, ½Ã¾ß °á¼Õ µîÀ» ÈçÈ÷ º¼ ¼ö ÀÖ´Ù. ¼Ò³ú ³ó¾çÀÇ °æ¿ì¿¡´Â ¼öÆò¼º ¾È±¸ ÁøÅÁ
  • brain center
    ´ë³ú ÁßÃß
  • brain concussion
    ³úÁøÅÁ
    µÎºÎ¿¡ °­ÇÑ ¿Ü·ÂÀÌ ÀÛ¿ëÇÑ Á÷ÈÄ¿¡ ÀϾ´Â Áõ¼¼. µÎºÎ¿¡ ¿Ü·ÂÀÌ ÀÛ¿ëÇÔ°ú µ¿½Ã¿¡ Àϰú¼ºÀÇ ÀÇ½Ä ¼Ò½ÇÀ» ÀÏÀ¸Å°Áö¸¸ ³ú ½ÇÁúÀÇ ÆÄ±«´Â ÀϾÁö ¾ÊÀº »óÅÂÀÌ´Ù. ´Ü½Ã°£
  • brain death syndrome
    ³ú»ç ÁõÈıº
  • brain function mapping
    ³ú ±â´É ÁöµµÈ­
  • brain injury
    ³ú ¼Õ»ó
  • brain peptide
    ³ú ÆéƼµå
  • brain sand
    ³ú»ç
    ³úÀÇ ÀÏÁ¤ ºÎºÐ¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÛÀº ¸ð·¡ ¸ð¾çÀÇ ´Ü´ÜÇÑ ÀÔÀÚ. ¼®È¸°¡ Ä§ÂøµÇ¾î »ý±ä °ÍÀÌ´Ù. ³ú»ç°¡ ¸ð¿© ÀÖ´Â ºÎÀ§´Â º¸Åë ¼Û°ú¼±°ú ±× ºÎ±ÙÀε¥ ÀþÀº »ç¶÷¿¡°Ô´Â ¾ø°í ³ëÀο¡°Ô ¸¹´Ù. ±×·¯¹Ç·Î À̰ÍÀº ÅðÈ­ Çö»óÀ¸·Î »ý°¢µÇ¸ç, ¶Ç ³ú»çÀÇ ³»ºÎ¿¡´Â ÁÙ¹«´Ì°¡ ÀÖ´Â °ÍÀ¸·Î º¸¾Æ óÀ½¿¡´Â ÀÛÀº °ÍÀÌ Â÷Â÷ Ä¿Áø °ÍÀ̶ó »ý°¢µÈ´Ù. µ¿½É¼ºÀÇ Çϳª ÇϳªÀÇ ³ú»ç ÇüÅ´ ±¸»óÀÌ ¸¹°í, Ç¥¸éÀº »Í³ª¹« ¿­¸Å ¸ð¾çÀ¸·Î ¿ïÅüºÒÅüÇÏ´Ù. ³ú»ç°¡ ÁÖ¼ººÐÀ¸·Î µÇ¾î °áÇÕÁ¶Á÷À̳ª Ç÷°ü°ú ¹¶ÃÄÁø µ¢¾î¸®°¡ µå¹°°Ô ³úÀÇ ³»ºÎ ¶Ç´Â ±× °¡±îÀÌ¿¡ »ý±â´Â °æ¿ì°¡ ÀÖ´Ù. ±×°ÍÀ» ³ú»çÁ¾À̶ó Çϴµ¥, À̰Ϳ¡ ÀÇÇÏ¿© ³ú Á¶Á÷ÀÌ ¾Ð¹Ú ¶Ç´Â ÆÄ±«µÇ¸é ±×¿¡ µû¸£´Â Áõ¼¼°¡ ³ªÅ¸³­´Ù. ¸Å¿ì Å« ³ú»çÁ¾ÀÌ Á¦ 4³ú½Ç¿¡ »ý°Ü ¼ö¾×ÀÇ È帧À» ¹æÇØÇÏ´Â ¿¹µµ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
minimal infecting dose <microbiology> The smallest quantity of infectious material regularly producing infection; usually expressed as I.D.50, the quantity causing infection in 50% of a suitable series of animals or cells (cell cultures).
(05 Mar 2000)
minimal inhibitory concentration <microbiology, pharmacology> The lowest concentration of antibiotic sufficient to inhibit bacterial growth when tested in vitro.
(05 Mar 2000)
minimal lethal dose <pharmacology> The minimal dose of a toxic substance or infectious agent that is lethal, as assayed in various experimental animals (e.g., the least amount of diphtheria toxin that, on an average, kills a 250-g guinea pig within 96 hours after subcutaneous inoculation).
When followed by a subscript (generally "MLD50"), denotes the minimal dose that is lethal to a certain percentage (e.g., 50%) of animals so assayed, LD05.
See: lethal dose.
(05 Mar 2000)
minimal medium <cell culture> The simplest tissue culture medium that will support the proliferation of normal cells.
(18 Nov 1997)
minimal reacting dose The minimal dose of a toxic substance causing a reaction, as manifested in the skin of a series of susceptible test animals; the assay is based on the development of a characteristic, minimal but definite, "standard," focal inflammation (congestion and oedema, induration, degenerative changes, and desquamation of epidermal cells).
(05 Mar 2000)
acute brain syndrome <syndrome> A condition of severe confusion or rapid change in brain function. This often occurs as the result of a mental illness or physical illness.
Symptoms include lethargy, agitation, confusion, disorientation and delirium.
(27 Sep 1997)
acute organic brain syndrome <syndrome> A constellation of behavioural or psychological signs and symptoms including problems with attention, concentration, memory, confusion, anxiety, and depression caused by transient or permanent dysfunction of the brain.
Synonym: acute organic brain syndrome, OBS, organic mental syndrome.
(05 Mar 2000)
anterior part of anterior commissure of brain The anterior part of the anterior or rostral commissure of the brain.
Synonym: pars anterior commissurae rostralis, pars anterior commissurae anterioris cerebri.
(05 Mar 2000)
arachnoid of brain That portion of the arachnoid which lies within the cranial cavity and surrounds the brain and the cranial portion of the subarachnoid space. In several sites it is relatively widely-separated from the pia mater, creating the cranial subarachnoid cisterns.
Synonym: arachnoid mater cranialis, arachnoid mater encephali, cerebral part of arachnoid.
(05 Mar 2000)
base of brain The inferior surface of the brain visible when seen from below.
Synonym: facies inferior cerebri, basis cerebri, inferior cerebral surface.
(05 Mar 2000)
big brain <molecular biology> Neurogenic gene of Drosophila, believed to encode a product involved in cell cell communication, perhaps via gap junctions. Member of the major intrinsic protein family.
(18 Nov 1997)
blood-brain barrier <pharmacology, physiology> A protective barrier formed by the blood vessels and glia of the brain. It prevents some substances in the blood from entering brain tissue.
The blood vessels of the brain (and the retina) are much more impermeable to large molecules (like antibodies) than blood vessels elsewhere in the body. This has important implications for the ability of the organism to mount an immune response in these tissues, although the basis for the difference in endothelial permeability is not well understood.
(16 Dec 1997)
brain One of the two components of the central nervous system, the brain is the centre of thought and emotion. It is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
(22 May 1997)
brain abscess A localised cavity filled with pus secondary to a bacterial infection.
(27 Sep 1997)
brain abscess in kids <radiology> Cyanotic congenital heart disease, e.g., tetralogy of Fallot, most important predisposing factor, blood not filtered by pulmonary capillaries
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • brain drain
    µÎ³úÀ¯Ãâ
  • brain fever
    ³ú¸·¿°
  • brain pan
    =skull
  • brain picker
    ³²ÀÇÁöÇý¸¦ÀÌ¿ëÇϴ»ç¶÷
  • brain storm
    Á¤½ÅÂø¶õ;°©Àڱ⠶°¿À¸¥ ¹¦¾È;¿µ°¨
  • brain trust
    ºê·¹ÀÎÆ®·¯½ºÆ®;Á¤ºÎÀÇ Á¤Ã¥ °í¹®´Ü
  • brain truster
    Á¤Ã¥ °í¹®
  • brain truster
    Á¤Ã¥°í¹®
  • brain wave
    ³úÆÄ;¿µ°¨;¹¦¾È
  • brain work
    Á¤½Å³ëµ¿ÀÚ
  • electronic brain
    ÀüÀÚ µÎ³ú(ÀüÀÚ °è»ê±â µûÀ§)
  • mechanical brain
    Àΰø µÎ³ú 
  • right-brain
    ¿ì³ú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á